Jonathan L. Sessler | |
|---|---|
 Jonathan L. Sessler | |
| Born | 20 May 1956 |
| Citizenship | American |
| Education | MSc at University of California, Berkeley PhD at Stanford University Postdoc at Louis Pasteur University |
| Alma mater | University of California Stanford University |
| Known for |
|
| Scientific career | |
| Institutions | University of Texas at Austin |
| Thesis | (1982) |
| Doctoral advisor | James P. Collman[1] |
Jonathan Sessler (born 20 May 1956 in Urbana, Illinois) is a professor of chemistry at The University of Texas at Austin. He is notable for his pioneering work on expanded porphyrins and their applications to biology and medicine. He is a co-founder of Pharmacyclics, Inc., a company that works with expanded porphyrins, and Anionics, Inc., which develops anion recognition chemistry. Pharmacyclics was sold to AbbVie for $21 billion in 2015.[2][3]
- ^ "Jonathan L Sessler". utexas.edu. UT Experts.
- ^ "AbbVie Completes Acquisition of Pharmacyclics | AbbVie Newsroom". news.abbvie.com. Retrieved 2018-07-11.
- ^ "AbbVie buys cancer drugmaker Pharmacyclics in $21B deal". USA TODAY. Retrieved 2018-07-11.